{
}
UBS has maintained a 'Buy' rating for Symrise, setting a price target of 138 euros. Analyst Charles Eden noted the potential for positive price drivers from the upcoming Capital Markets Day, highlighting Symrise among key stocks to watch in the flavor and fragrance sector. As of November 15, 2024, Symrise shares were trading at approximately 103.75 euros, reflecting a slight decline of 0.57%.
UBS has maintained a "Buy" rating for Symrise, setting a target price of 138 euros. Analyst Charles Eden noted the stock's potential for positive price drivers ahead of the upcoming Capital Markets Day, highlighting it as one of three noteworthy picks in the flavor and fragrance sector.
UBS AG has maintained a "Buy" rating for Symrise shares, setting a price target of 138 euros, indicating a potential upside of 32.69% from the current price of 104 euros. Analyst Charles Eden anticipates positive developments from the upcoming Capital Markets Day, with Symrise's Q4 2024 results expected on March 5, 2025. The stock has seen a 5.5% increase since the start of 2024, with 125,525 shares traded recently on XETRA.
UBS has maintained a "Buy" rating for Symrise AG, setting a price target of 138 euros. Analyst Charles Eden noted the potential for positive price drivers from the upcoming Capital Markets Day, highlighting Symrise as a key stock to watch in the flavor and fragrance sector.
UBS has maintained a "Buy" rating for Symrise shares with a price target of €138, anticipating new financial targets at the upcoming capital market day. Analyst Charles Eden predicts a more ambitious EBITDA margin, which could positively influence the share price. Currently, Symrise shares are trading at €104.05, reflecting a 0.3% decline, but still show a potential upside of 32.63%.
UBS AG maintains a "Buy" rating for Symrise shares with a price target of €138, anticipating new financial targets at the upcoming capital market day. Currently, the share price is down 0.2% at €104.10, indicating a potential upside of 32.56%. The stock has increased by 5.6% since the start of 2024, with the Q4 2024 balance sheet expected on March 5, 2025.
UBS AG has maintained a "Buy" rating for Symrise shares, setting a price target of 138 euros ahead of the company's capital market day. Analyst Charles Eden anticipates the announcement of new financial targets, including a more ambitious operating margin, which could positively influence the share price. Currently, Symrise shares are trading at 104.10 euros, reflecting a potential upside of 32.56% relative to the target price.
UBS AG maintains a "Buy" rating for Symrise shares with a target price of €138, highlighting potential upside of 32.12% from the current price of €104.45. The focus is on the upcoming capital market day on November 19-20, where updates on the 2024 margin target and growth prospects will be discussed. The share price has increased by 6.0% since the start of 2024, with Q4 2024 financial results expected on March 5, 2025.
UBS AG has maintained a "Neutral" rating for Givaudan shares, setting a target price of 4,520 francs, despite concerns over potential sales slowdowns in Q4. Currently priced at CHF 3,836.00, the shares have a 17.83% upside potential and have risen 12.0% since the start of 2024. Key Q4 figures are expected on January 24, 2025.
UBS has maintained a 'Buy' rating for Symrise, setting a target price of 138 euros following a recent conference. Analyst Charles Eden highlighted the upcoming capital market day on November 19-20, where updates on the 2024 margin target and growth prospects will be discussed. Symrise, a leader in fragrances and flavors, generates 63% of its sales from nutritional ingredients and 37% from fragrances and flavors, with significant market presence across various regions.
Charles Eden
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs maintains buy rating for symrise with target price of 138 euros
13:49 15.11.2024
ubs maintains buy rating for symrise with target price of 138 euros
13:49 15.11.2024
ubs maintains buy rating for symrise with price target of 138 euros
13:37 15.11.2024
UBS maintains buy rating for Symrise with price target of 138 euros
13:15 15.11.2024
ubs maintains buy rating for symrise with price target of 138 euros
11:34 15.11.2024
UBS maintains buy rating for Symrise with price target of 138 euros
11:34 15.11.2024
UBS maintains buy rating for Symrise shares with 138 euro price target
10:34 15.11.2024
ubs maintains buy rating for symrise with target price of 138 euros
12:28 14.11.2024
ubs maintains neutral rating for givaudan with target price of 4520 francs
12:28 14.11.2024
UBS maintains buy rating for Symrise with target price of 138 euros
12:24 14.11.2024
Trending
Subcategory
Corporate News
Industry Trends
Global Trade Developments
Stock Market Updates
Startups & Entrepreneurship
Industry Mergers & Acquisitions
Inflation and Monetary Impact
Supply Chain Management
Cryptocurrency Trends
Private Equity Deals
Government Economic Policies
Central Bank Actions
Central Banks and Digital Currencies
Fintech Startups
CEO Changes
Workplace Trends
Blockchain Infrastructure Development
Crypto Policies and Governance
Banking Regulations
Finance Mergers & Acquisitions
Countries:
Companies:
Apple Inc.
Foxconn Technology Co., Ltd.
NVIDIA Corporation
Nasdaq 100 Jun 25
Boeing Co
Airbus SE
Amazon.com, Inc.
Oracle AI USD
AppLovin Corp.
Tesmec S.p.A.
DeepSeek R1 USD
LG Electronics Inc.
Tesla, Inc.
MARA Holdings, Inc.
Cleanspark Inc
Citigroup Inc.
Vodafone Idea Limited
JM Financial Limited
Fuse Science, Inc.
Arla Foods A.M.B.A.
Currencies:
United States Dollar
Euro
Chinese Yuan
Indian Rupee
New Taiwan Dollar
Egyptian Pound
Hong Kong Dollar
Malaysian Ringgit
Indonesian Rupiah
Filipino Peso
West African CFA Franc
Japanese Yen
People: